We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$17.2B
AUM Growth
+$1.4B
Cap. Flow
+$543M
Cap. Flow %
3.15%
Top 10 Hldgs %
62.73%
Holding
1,140
New
150
Increased
453
Reduced
383
Closed
150

Top Buys

Rank Stock Value
1
HESM icon
Hess Midstream
HESM
+$255M
2
ET icon
Energy Transfer Partners
ET
+$168M
3
SUN icon
Sunoco
SUN
+$143M
4
WES icon
Western Midstream Partners
WES
+$97.8M
5
CQP icon
Cheniere Energy
CQP
+$79.7M

Top Sells

Rank Stock Value
1
ENLC
ENLINK MIDSTREAM, LLC
ENLC
+$706M
2
CCJ icon
Cameco
CCJ
+$31.2M
3
FSM icon
Fortuna Silver Mines
FSM
+$12M
4
MPLX icon
MPLX
MPLX
+$11.4M
5
UEC icon
Uranium Energy
UEC
+$10.8M

Sector Composition

Rank Sector Weight
1 Energy 69.95%
2 Technology 3.96%
3 Financials 3.32%
4 Consumer Discretionary 3%
5 Utilities 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONL
951
Orion Office REIT
ONL
$148M
$240K ﹤0.01%
112,115
+34,755
+45% +$121K
AMLX icon
952
Amylyx Pharmaceuticals
AMLX
$2.05B
$239K ﹤0.01%
67,597
+12,167
+22% +$43.3K
UPB
953
Upstream Bio Inc
UPB
$349M
$239K ﹤0.01%
39,079
-4,261
-10% -$40.7K
RIGL icon
954
Rigel Pharmaceuticals
RIGL
$680M
$236K ﹤0.01%
13,100
-1,140
-8% -$23.1K
ATXS
955
DELISTED
Astria Therapeutics
ATXS
$232K ﹤0.01%
43,444
-2,186
-5% -$15.3K
ZBIO
956
Zenas BioPharma
ZBIO
$1.92B
$222K ﹤0.01%
28,132
-5,658
-17% -$44.3K
AURA icon
957
Aura Biosciences
AURA
$729M
$218K ﹤0.01%
37,156
-3,236
-8% -$24.5K
PLL
958
DELISTED
Piedmont Lithium
PLL
$212K ﹤0.01%
33,637
+17,097
+103% +$137K
ARCT icon
959
Arcturus Therapeutics
ARCT
$157M
$211K ﹤0.01%
19,949
-1,952
-9% -$31K
IIPR icon
960
Innovative Industrial Properties
IIPR
$1.78B
$209K ﹤0.01%
+3,868
New +$268K
RC
961
Ready Capital
RC
$265M
$195K ﹤0.01%
38,398
-1,396
-4% -$8.6K
VNDA icon
962
Vanda Pharmaceuticals
VNDA
$312M
$193K ﹤0.01%
41,993
-5,156
-11% -$24K
MBX
963
MBX Biosciences
MBX
$2.95B
$192K ﹤0.01%
26,034
-986
-4% -$10.4K
OLMA icon
964
Olema Pharmaceuticals
OLMA
$1.02B
$190K ﹤0.01%
50,484
+4,149
+9% +$20.9K
CMPS
965
Compass Pathways
CMPS
$1.52B
$189K ﹤0.01%
66,231
+10,899
+20% +$41.9K
SLRN
966
DELISTED
ACELYRIN
SLRN
$184K ﹤0.01%
74,640
-6,489
-8% -$15.4K
IRWD icon
967
Ironwood Pharmaceuticals
IRWD
$611M
$172K ﹤0.01%
116,860
-12,537
-10% -$29.9K
ITOS
968
DELISTED
iTeos Therapeutics
ITOS
$171K ﹤0.01%
28,646
-894
-3% -$6.56K
ASM
969
Avino Silver & Gold Mines
ASM
$987M
$169K ﹤0.01%
92,088
+38,002
+70% +$51.8K
ANNX icon
970
Annexon
ANNX
$855M
$159K ﹤0.01%
82,626
-3,568
-4% -$11.9K
ELDN icon
971
Eledon Pharmaceuticals
ELDN
$276M
$151K ﹤0.01%
44,436
-3,874
-8% -$15.9K
YMAB
972
DELISTED
Y-mAbs Therapeutics
YMAB
$148K ﹤0.01%
33,309
-2,906
-8% -$16.9K
SITC icon
973
SITE Centers
SITC
$230M
$136K ﹤0.01%
10,629
-386
-4% -$5.5K
CRGX
974
DELISTED
CARGO Therapeutics
CRGX
$135K ﹤0.01%
33,158
-4,064
-11% -$27.2K
RZLT icon
975
Rezolute
RZLT
$480M
$125K ﹤0.01%
43,086
-3,764
-8% -$16.4K
37 38
39
40 41

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, ALPS Advisors held 1,140 positions worth $17.2B, up 8.8% from $15.8B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

ALPS Advisors deployed $543M of net new capital in Q1 2025, opening 150 new positions and adding to 453 existing holdings. Its largest new stake was Sprott Physical Silver Trust: 763,746 shares worth $8.86M.

By sector, the portfolio is most concentrated in Energy at 70% of assets, up from 69% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cameco, an estimated $31.2M trimmed.

  • ALPS Advisors's largest Q1 2025 buy was Sprott Physical Silver Trust: 763,746 shares worth $8.86M.
  • ALPS Advisors added most to Hess Midstream in Q1 2025, an estimated $255M increase.
  • ALPS Advisors's biggest Q1 2025 reduction was Cameco, cutting an estimated $31.2M.
  • ALPS Advisors fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $706M.
  • ALPS Advisors's ten largest holdings make up 63% of its $17.2B portfolio in Q1 2025.
  • ALPS Advisors opened 150 new positions and closed 150 in Q1 2025.
  • ALPS Advisors's portfolio value rose 8.8% quarter-over-quarter to $17.2B.

Based on ALPS Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.